Eiko Lifesciences Ltd — Important, 11-12-2025: Company Update

Eiko LifeSciences' board approved the acquisition of 51% of SSM Formulations Private Limited for 18 Cr, a pharmaceutical manufacturing company. This strategic move aims to diversify Eiko's product portfolio and strengthen its position in specialty chemicals and APIs. SSM Formulations reported turnover of 27.65 Cr, 41.41 Cr, and 50.82 Cr for the last three fiscal years. Additionally, the board approved raising funds up to 18.15 Cr through preferential issue of 33 lakh warrants, and 3.71 Cr through preferential issue of 6.75 lakh equity shares, both priced at Rs. 55 each. These proposals require shareholder approval at an upcoming Extra Ordinary General Meeting.